| Articles Reviewed |
| 1: | Aristotelis Astrinidis et al. Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner. 2006 |
| 2: | Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
| 3: | Eileen Connolly et al. Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells. 2006 |
| 4: | Annett Hahn-Windgassen et al. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. 2005 |
| 5: | Michael N Corradetti et al. The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway. 2005 |
| 6: | Takahiro Nobukuni et al. Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. 2005 |
| 7: | Francesco Andreozzi et al. Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells. 2004 |
| 8: | Vanishree Murthy et al. Pam and its ortholog highwire interact with and may negatively regulate the TSC1.TSC2 complex. 2004 |
| 9: | Magdalena Karbowniczek et al. Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent. 2004 |
| 10: | Kurt J Sales et al. Prostaglandin E2 mediates phosphorylation and down-regulation of the tuberous sclerosis-2 tumor suppressor (tuberin) in human endometrial adenocarcinoma cells via the Akt signaling pathway. 2004 |
| 11: | Yong Li et al. The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3. 2003 |
| 12: | Xiao-Ding Peng et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. 2003 |
| 13: | David J Kwiatkowski et al. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. 2002 |
| 14: | Heidi L Kenerson et al. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. 2002 |
| 15: | Matt Y Liu et al. 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). 2002 |
| 16: | Luciana A Haddad et al. The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton. 2002 |